1. Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights.
   Ammad Ahmad Farooqi et al, 2019, Semin Cancer Biol CrossRef
2. CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis
   Naresh Poondla et al, 2019, Biochemical and Biophysical Research Communications CrossRef
3. Natural products for treating colorectal cancer: A mechanistic review
   Xuan-mei Huang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
4. RIP-1/c-FLIPL Induce Hepatic Cancer Cell Apoptosis Through Regulating Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
   Jichun Sun et al, 2017, Med Sci Monit CrossRef
5. Pseudolaric Acid B Induces Growth Inhibition and Caspase-Dependent Apoptosis on Head and Neck Cancer Cell lines through Death Receptor 5
   Su-Jung Choi et al, 2019, Molecules CrossRef
6. Interleukin-8 in Hyperlipidemia and Coronary Heart Disease in Thai Patients Taking Statin Cholesterol-Lowering Medication While Undergoing Coronary Artery Bypass Grafting Treatment
   Wilanee Dechkhajorn et al, 2020, Scientifica CrossRef
7. Downregulation of c‑FLIP and upregulation of DR‑5 by cantharidin sensitizes TRAIL‑mediated apoptosis in prostate cancer cells via autophagy flux
   Uddin Nazim et al, 2020, Int J Mol Med CrossRef
8. p38 inhibitor inhibits the apoptosis of cowanin-treated human colorectal adenocarcinoma cells
   Nittiya Chowchaikong et al, 2018, Int J Oncol CrossRef
9. Mechanism of apoptosis induction associated with ERK1/2 upregulation via goniothalamin in melanoma cells
   Suphakorn Tangchirakhaphan et al, 2018, Exp Ther Med CrossRef
10. Human apoptosis antibody array-membranes studying the apoptotic effect of marine bacterial exopolysaccharides in HepG2 cells
    SalmaM Abdelnasser et al, 2020, J Can Res Ther CrossRef
11. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling
    Hao Liu et al, 2021, Journal of Immunology Research CrossRef
12. Death Receptor 5 (TNFRSF10B) Is Upregulated and TRAIL Resistance Is Reversed in Hypoxia and Normoxia in Colorectal Cancer Cell Lines after Treatment with Skyrin, the Active Metabolite of Hypericum spp.
    Marián Babinčák et al, 2021, Cancers CrossRef
13. Behind the Adaptive and Resistance Mechanisms of Cancer Stem Cells to TRAIL
    Adriana G. Quiroz-Reyes et al, 2021, Pharmaceutics CrossRef
14. Natural substances derived from herbs or plants are promising sources of anticancer agents against colorectal cancer via triggering apoptosis
    Zi-Bo Liu et al, 2021 CrossRef
15. Colon cancer and colorectal cancer: Prevention and treatment by potential natural products.
    Md Rezaul Islam et al, 2022, Chem Biol Interact CrossRef
16. Indirubin Inhibits TRAIL-Induced Activation of Death Receptor 5 in Jurkat Cells
    Malaney C. Young et al, 2023, Natural Product Communications CrossRef
17. Significance of TRAIL/Apo-2 ligand and its death receptors in apoptosis and necroptosis signalling: Implications for cancer-targeted therapeutics
    Avik Maji et al, 2024, Biochemical Pharmacology CrossRef
18. Nanoparticle-Mediated Gene Delivery of TRAIL to Resistant Cancer Cells: A Review
    Mina Habibizadeh et al, 2024, Heliyon CrossRef
19. Chromene-based compounds as drug candidates for renal and bladder cancer therapy – A systematic review
    Mónica Costa Cerqueira et al, 2024, Bioorganic Chemistry CrossRef